276 top medical experts on Metachromatic Leukodystrophy across 39 countries and 26 U.S. states, including 112 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Metachromatic Leukodystrophy: An autosomal recessive metabolic disease caused by a deficiency of cerebroside-sulfatase leading to intralysosomal accumulation of cerebroside sulfate (sulfoglycosphingolipids) in the nervous system and other organs. Pathological features include diffuse demyelination, and metachromatically-staining granules in many cell types such as the glial cells. There are several allelic and nonallelic forms with a variety of neurological symptoms.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Hereditary Central Nervous System Demyelinating Diseases (1,644).
  4. Clinical Trials ClinicalTrials.gov : at least 34 including 9 Active, 10 Completed, 7 Recruiting
  5. Synonyms: Arylsulfatase A Deficiency Disease,  Cerebroside Sulphatase Deficiency Disease


  

        

                    


    Computing Expert Listing ...

);